Inventor · disambiguated record
Paul A. Jaminet
Also filed as: JAMINET PAUL A
3 granted patents·10 pending applications·7 citations·filing 2018–2024
56Inventor score
Top patents by PatentIndex Score
13 records- 0189US11208495B2Anti-TM4SF1 antibodies and methods of using sameANGIEX INC·Filed 2018·Granted Dec 28, 2021·7 cites·15 claims
- 0266US2022267461A1Anti-tm4sf1 antibodies and methods of using sameANGIEX INC·Filed 2021·Application pending·0 cites
- 0366US2022153860A1Anti-tm4sf1 antibodies and methods of using sameANGIEX INC·Filed 2021·Application pending·0 cites
- 0459US2025152730A1Anti-tm4sf1 antibody-drug conjugates comprising cleavable linkers and methods of using sameANGIEX INC·Filed 2024·Application pending·0 cites
- 0558US2024342302A1Degrader-antibody conjugates and methods of using sameANGIEX INC·Filed 2024·Application pending·0 cites
- 0658US2024156978A1Maytansine-antibody conjugates and methods of using sameANGIEX INC·Filed 2023·Application pending·0 cites
- 0757US2023372518A1Antimitotic tetrapeptide-antibody conjugates and methods of using sameANGIEX INC·Filed 2023·Application pending·0 cites
- 0856US2024166759A1Combinations comprising anti-tm4sf1 antibodies and immunotherapeutic agents and methods of using the sameANGIEX INC·Filed 2023·Application pending·0 cites
- 0952US2023293713A1Anti-tm4sf1 antibody drug conjugates and methods of using sameANGIEX INC·Filed 2022·Application pending·0 cites
- 1051US2023126271A1Degrader-antibody conjugates and methods of using sameANGLEX INC·Filed 2022·Application pending·0 cites
- 1150US2023338572A1Anti-tm4sf1 antibody-drug conjugates comprising cleavable linkers and methods of using sameANGIEX INC·Filed 2023·Application pending·0 cites
- 1244US12458705B2Antibody-oligonucleotide conjugatesANGIEX INC·Filed 2019·Granted Nov 4, 2025·0 cites·12 claims
- 1342US12428477B2Antibody-drug conjugates comprising anti-TM4SF1 antibodies and methods of using the sameANGIEX INC·Filed 2020·Granted Sep 30, 2025·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Paul A. Jaminet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →